Table 2.
SARS-CoV-2 testing and positivity in November and December 2021 and total sequenced. SARS-CoV-2 testing is performed by different molecular assays as detailed in the methods section and the total tested reflects testing by all assays. Sequence counts were up to the time of writing this manuscript.
| November | December | November | December | |
|---|---|---|---|---|
| SARS-CoV-2 (All testing) | 726 | 7078 | 2.67 | 18.65 |
| SARS-CoV-2 (Symptomatic only) | 592 | 6236 | 5.70 | 25.50 |
| % | ||||
| Total sequenced | 552 | 2179 | 76.03 | 30.79 |
| 21I (Delta) | 24 | 36 | 4.35 | 1.65 |
| 21J (Delta) | 468 | 791 | 84.78 | 36.30 |
| 21K (Omicron) | 1 | 1208 | 0.18 | 55.44 |
| Other or low QC | 59 | 144 | 10.69 | 6.61 |